Skip to Main Content

Paper Details

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.
Cancer Res
346
2005
AKT, EGFR, EGFR coding sequence, EGFR gene, EGFR inhibitory antibody cetuximab, EGFR tyrosine kinase, Epidermal growth factor receptor, ErbB family members, ErbB2, ErbB3, H1819, HCC827, HER, HER family members, HER receptor family, NSCLC, NSCLC cell line, NSCLC cells, cell lines, epidermal growth factor receptor, erlotinib, exon 19, gefitinib, lung cancer, lung cancer cell lines, non-small cell lung cancer, tyrosine, tyrosine kinase domain, wild-type EGFR

Datasets

Release 1.2